Biolife Solutions INC Form 4 insider transactions

BioLife Solutions' Chief Quality and Operations, Karen A. Foster, sold 335 shares of common stock to cover tax withholding obligations.

BIOLIFE SOLUTIONS Chief Human Resources Officer, Sarah Aebersold, sold 241 shares of common stock to cover tax withholding obligations.

BioLife Solutions' EVP and Chief Scientific Officer, Aby J. Mathew, sold 405 shares of common stock to cover tax withholding obligations.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 344 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Aby J. Mathew, EVP & Chief Scientific Officer at BioLife Solutions Inc., sold 631 shares of common stock to satisfy tax withholding obligations.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 1,033 shares of common stock to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 946 shares of common stock in December 2025 to satisfy tax withholding obligations from restricted stock vesting.

BIOLIFE SOLUTIONS Director Amy DuRoss reported a pre-scheduled sale of 2,000 common stock shares at $24.6 each.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 358 shares of common stock at $25.13 per share to cover tax withholding obligations related to restricted stock vesting.

BioLife Solutions' Chief Quality and Operations, Karen A. Foster, sold 519 shares of common stock to cover tax withholding obligations.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 30,000 shares of common stock for approximately $25.72 per share under a pre-arranged trading plan.

BioLife Solutions Director Amy DuRoss sold 4,000 shares of common stock for $108,000 through a pre-arranged trading plan.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 351 shares of common stock to cover tax withholding obligations from restricted stock vesting.

BioLife Solutions CFO Troy Wichterman sold 584 shares of common stock for $26.74 per share to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 217 shares of common stock for $26.74 per share to cover tax withholding obligations.

BioLife Solutions' Chief Quality and Operations, Karen A. Foster, sold 415 shares of common stock for tax withholding purposes.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 110 shares of common stock for $26.74 per share to cover tax withholding obligations under a pre-arranged 10b5-1 plan.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 526 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

BioLife Solutions Director Amy DuRoss reported selling 6,000 shares of common stock over three days in November 2025.

BioLife Solutions' President and CEO, Roderick De Greef, reported the sale of 100,000 shares of common stock in multiple transactions under a pre-arranged Rule 10b5-1 trading plan.

BioLife Solutions Director Joydeep Goswami sold 1,666 shares of common stock for $28.99 per share under a pre-arranged 10b5-1 trading plan.

BioLife Solutions President and CEO, Roderick de Greef, sold 37,795 shares of common stock at $27.3 per share to cover tax withholding obligations.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 275 shares of common stock at $27.82 per share to cover tax withholding obligations.

Joydeep Goswami, a Director at BioLife Solutions Inc., sold 1,334 shares of common stock on October 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Casdin Partners Master Fund, a significant shareholder and director of BioLife Solutions Inc., divested 750,000 shares of common stock for approximately $21.4 million.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 833 shares of common stock for tax withholding obligations under a pre-arranged trading plan.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 289 shares of common stock for $27.36 per share to cover tax withholding obligations related to restricted stock vesting.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 509 shares of common stock for $27.36 each to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 188 shares of common stock at $27.36 per share to cover tax withholding obligations.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions, sold 419 shares of common stock to cover tax withholding obligations.